78 results on '"Stewart, Paul"'
Search Results
2. Impact of glucocorticoid-induced adrenal insufficiency on health-related quality of life in patients receiving long-term low dose prednisolone treatment: Results from the double edge-rescue trial
3. Assessment of adrenal function after prednisolone treatment in patients with polymyalgia rheumatica and/or giant cell arteritis - Data from the double edge-replace study
4. Controlling intracellular cortisol: Can HSD-1 inhibition reduce Cushing's syndrome morbidity and minimize adrenal insufficiency risk?
5. Impairment of the HPA axis after treatment with glucocorticoids
6. Glucocorticoid-induced adrenal insufficiency: Identification of diagnostic and prognostic biomarkers based on two randomized controlled trials - REFINE
7. Controlling intracellular cortisol: Can HSD-1 inhibition reduce Cushing's syndrome morbidity and minimize adrenal insufficiency risk?
8. Glucocorticoid-induced adrenal insufficiency: Identification of diagnostic and prognostic biomarkers based on two randomized controlled trials - REFINE
9. 11β-HSD1 contributes to age-related metabolic decline in male mice
10. Mild autonomous cortisol secretion in patients with adrenal incidentalomas and raised cardiovascular risk
11. Mild autonomous cortisol secretion in patients with adrenal incidentalomas and raised cardiovascular risk
12. A randomised controlled pilot trial of oral 11[beta]-HSD1 inhibitor AZD4017 for wound healing in adults with type 2 diabetes mellitus
13. Phase II study of the impact of AZD4017, a selective 11β-HSD1 inhibitor, on osteocalcin in post-menopausal osteopenia
14. 11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: A randomized, double-blind, placebo-controlled trial
15. From bench to bedside and beyond: a novel therapy to improve wound healing in type 2 diabetes
16. The urinary cortisol metabolome in patients with adrenal insufficiency: dual-release hydrocortisone is less deleterious than conventional hydrocortisone therapy
17. Urinary steroid profile in patients with primary adrenal insufficiency under conventional glucocorticoid replacement: a case control study
18. Suppression of 11[beta]-hydroxysteroid dehydrogenase type 1 target gene regulation by hypoxia
19. The ever changing facets of Cushing's syndrome
20. 11[beta]-hydroxysteroid dehydrogenase type 1 mediates anti-inflammatory, pro-inflammatory and inflammation-independent effects in primary human dermal fibroblasts
21. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy
22. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism
23. Increased morbidity and hospital admissions in patients with adrenal insufficiency
24. 11[beta]-HSD1 is a regulator of brown adipose tissue function and mediates stress adaptation in glucocorticoid excess
25. Should we treat subclinical Cushing's syndrome?
26. 11[beta]-HSD1-mediated decrease in COX2 expression is abrogated by hypoxia in human dermal fibroblasts
27. Glucocorticoid-induced lipolysis across human ageing and the relationship to fat mass and androgens
28. Longitudinal changes in adipose tissue gene expression profile are asociated with deteriorating glucose tolerance
29. Using a morning cortisol to predict adrenal reserve and guide management
30. Defining and exploring the excessive healthcare burden of adrenal insufficiency
31. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure
32. Enhanced expression of hepatic inflammatory markers in 11[beta]-hydroxysteroid dehydrogenase type 1 knockout mice fed a steatogenic diet
33. Lack of 11[beta]-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing's syndrome
34. 11[beta] HSD1KO mice resist aged associated decline in markers of brown adipose tissue function
35. Adverse outcome in glucocorticoid induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
36. Bioinformatic analysis of altered microRNA production in normal adrenal tissue and aldosterone-producing adenoma
37. Hyperandrogenaemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione
38. Glucocorticoid activation in muscle by 11[beta]-hydroxysteroid dehydrogenase type 1: contributions to inflammatory muscle wasting
39. High 11[beta]-HSD1 activity is associated with progression to rheumatoid arthritis in patients first presenting with inflammatory arthritis
40. Longitudinal changes in glucocorticoid metabolism predict the development of metabolic phenotype
41. Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
42. H6PDH deficiency in muscle impacts amino acid metabolism
43. TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle
44. Glucocorticoids enhance insulin sensitivity in human hepatocytes
45. 11b-HSD1KO mice are protected from glucocorticoid dependent age-associated muscle atrophy
46. Hepatic 11[beta]-hydroxysteroid dehydrogenase type 1 is elevated following weight loss secondary to bariatric surgery
47. TNFa directly regulates in vivo corticosteroid metabolism in inflammatory arthritis
48. 11b-HSD1 knockout mice are protected from the adverse metabolic effects of exogenous glucocorticoid excess
49. Truncal fat distribution is associated with enhanced glucocorticoid excretion, increased 5[alpha]-reductase activity and higher insulin resistance independent of BMI in women with polycystic ovary syndrome
50. A serum microRNA profile potentially associated with glucocorticoid mediated insulin resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.